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ELSEWHERE (Galluzzi and Payne, 1955) we have dealt in detail with the
sources and composition of 741 necropsies which form the basis of the present
article. The more general aspects of blood-borne spread were also considered in
the earlier work. Our purpose here is to consider specifically brain metastases
arising from bronchial carcinoma. The reason for dealing separately with this
topic is that it has been a matter of special interest for a number of years and
might add useful facts to the current discussions on the proportion of deaths
certified as lung cancer which is due to a real increase in the disease. Many
authors in the past have remarked on the prevalence of this mode of spread and
some, for example Willis (1953) and Bailey (1948) have discussed its natural
history and pathology in some detail.
Sources of the material
The necropsy reports which were studied were those relating to 741 patients
who died with carcinoma ofthe bronchus in eight London Hospitals (four teaching
and four regional board hospitals) during the years 1948-52. Amongst them were
94 necropsies in which no intracranial examination was made. Full details of
the sources of the material are given in Table I.
TABLE I.-The Sources of the Data
Number of
necropsies on Number with full
patients dying necropsy including
from bronchial intracranial
Hospital. carcinoma. examination.
Hammersmith Hospital . . 156 . 122
St. Mary Abbots Hospital . 113 90
Middlesex Hospital . . 87 . 58
St. George's Hospital . . 87 . 84
Archway Hospital . 83 . 82
St. Mary's Hospital, Islington . 99 . 99
Highgate Hospital . . 52 . 51
Royal Marsden Hospital . 64 . 61
All hospitals . 741 647
The incidence of brain metastases
In dealing with the incidence of brain metastases we are obliged to exclude
all those necropsies at which the brain was not examined. This is justifiable ifBRAIN METASTASES FROM BRONCHIAL CARCINOMA 4
these exclusions represent a random sample of the whole group. It is extremely
likely, however, that most of these patients had no neurological signs prior to
death so that, as a group, they are likely to contain a somewhat lower proportion
with brain metastases than the remainder.
In order to assess factors which may influence the tendency towards the
development ofbrain metastases we have to compare the proportions ofnecropsies
at which brain secondaries were noted when the material is classified in a variety
of ways, for example, according to sex, age, histology and site of primary.
(i) Differences between hospitals.-When the whole of the material was
considered it was found that the brain was surpassed only by the liver and
adrenals in frequency of being involved at death by blood-borne metastases from
bronchial carcinoma. In the present group 25.7 per cent of necropsies showed
brain secondaries though the corresponding figures for individual hospitals ranged
from 17 to 43 per cent. This may well represent a greater variation than can be
accounted for by case selection alone. The upper limit of 43 per cent does,
however, relate to the hospital with a special neurosurgical interest.
(ii) Differences according to sex.-There was no evidence of any difference
between the sexes in their tendency to develop brain secondaries. The incidence
figures for males and females were 25.7 and 25-5 per cent respectively.
(iii) Variation with age.-At first sight there would seem to be evidence of a
tendency for the incidence of metastases, and of brain metastases in particular,
to decrease with increasing age. This impression is examined critically in (v)
below.
(iv) Differences according to the histology of the primary tumour.-It is well
recognized that undifferentiated tumours have a marked tendency to metastasize.
The figures for brain metastases in this series were: undifferentiated 30-1 per
cent, adenocarcinoma 32-5 per cent and squamous celled carcinoma 10.7 per cent.
Let us consider the following hypothesis; "Whether a tumour metastasizes or
not depends chiefly on its histology but ifit metastasizes then the general pattern
of metastasis is independent of its histology." A crude test of this hypothesis
can be based on a consideration of the metastasis rates for individual organs and
the histological type expressed as a proportion of the number ofnecropsies reveal-
ing any metastases whatever. If the hypothesis is true we would expect that for
each organ, these conditional metastasis rates wouldbethe sameforeachhistology.
It has been shown (Galluzzi and Payne, 1955) that these rates are not generally
the same (especially in the case of the kidneys). In the case of brain, too, the
conditional rate for adenocarcinomas is brought into prominence being 41.5 per
cent compared with 32.5 per cent for undifferentiated tumours and 21-9 per cent
for squamous celled carcinoma.
(v) Variation with agefor individual hospitals.-We have referred in (i) above
to the variation in brain metastasis rates in the individual hospitals studied. We
can dividethese into threegroups:
(a) A hospital with special neurosurgical interests at which 43 per cent of
necropsies on patients with bronchial carcinoma revealed brain
metastases.
(b) Two hospitals for which, considered jointly, the corresponding figure
was about 30 per cent.
(c) The remaining five hospitals all of which yield a substantially lower
incidence.
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The variation of the rates with age for these three groups is illustrated in Fig. 1.
It will be seen that the hospital with a special neurosurgical interest shows a
particularly high rate in the fifties and the rate of 30 per cent for the second group
remains virtually constant with age. Only in the third group is there any
indication of a decline in incidence with age.
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FIG. I.-Age incidence of brain metastases by hospitals. (a) One hospital with neurosurgical
interests. (b) Two hospitals showing no decline with age. (c) Five other hospitals.
This situation is obviously one in which we will be inclined to accept the
greater values of a series of proportions as being nearer to a "true" value than
the average of the series of proportions always provided these proportions are
based on numbers large enough to render chance variations unimportant. We
are therefore inclined to suggest that brain metastases from bronchial carcinoma
occur at death in about 30 per cent of cases and that it is questionable whether
this proportion decreases with age.
(vi) Mechanical Factors.-As has been pointed out elsewhere (Galluzzi and
Payne, 1955) the high incidence of brain metastases in relation to metastases
elsewhere could be explained in terms of mass oftissue alone. There are however
exceptions to this simple hypothesis for example the skin, a large organ with a
low metastasis rate, and the adrenals, small organs with high rates.
Some statisticsfrom the literature
There are two quite distinct ways in which the stastistics on this subject
have been presented in the literature. The first has been simply to record the
proportion of necropsies on lung cancer patients in which brain metastases were
found. We have seen in the last section that this proportion is, in this investiga-
tion, 25-7 per cent, but that the true figure may be nearer 30 per cent. Table II
shows the extent to which the estimate of this proportion has varied in 40 years
of literature on the subject. It will be seen that although the more recent
investigations show, in general, a higher proportion of brain metastases, some
in the early part of the century (e.g. that of Dosquet, 1921) record more than 30
per cent and some ofthe later ones (e.g. that of Bryson and Spencer (1951) whioh
is by far the largest) record as low as 17 per cent.
The second type of statistic which has claimed attention is a statement of
the proportion of brain metastases found to have arisen from primary bronchial
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TABLE II.-Relative Frequency of Occurrence ofBrain Metastases from Primary
Carcinoma of the Lung asfound at Post-mortem by Various Authors.
Author.
Seyfarth (1924)
Olson (1935)
Wegelin (1942)
Mielecki (1913)
Dosquet (1921)
Levy Simpson (1929)
Rau (1921)
Klotz (1927)
Barron (1922)
Tuttle & Womack (1934)
Grove & Kramer (1926)
Brunner (1936)
Wustner (1941)
Dissman (1932)
Koletsky (1938)
Jaffe (1935)
Rogers (1932) .
Meyer & Reah (1953)
Bryson & Spencer (1951)
Knorr (1949) .
Halpert et al. (1954)
Periods
covered by
examinations.
1900-1924
1900-1934
1900-1940
1906-1912
1907-1920
1907-1925
1909-1919
1910-1927
1912-1921
1915-1933
1917-1924
1920-1933
1920-1939
1925-1931
1927-1937
1928-1933
1929-1930
1934-1950
1936-1947
1946-1947
1949-1953
Number
of full
necropsies
reviewed.
307
22
117
17
105
139
30
24
13
30
21
99
189
80
100
77
50
303
866
60
92
Number in
which brain
metastases
were found.
32
18
6
33
19
4
3
2
7
5
28
48
13
22
19
77
30
Per cent in
which brain
metastases
were found.
10
36
15
35
31
14
13
13
15
23
24
28
25
16
22
25
20
25
17
17
(inc. spinal
cord)
33
carcinomas. There are several factors which might cause this proportion to
vary chief among which are;
(a) The relative proportion of deaths from lung cancer as compared with
other cancers.
(b) The proportion of lung cancer deaths which come to necropsy.
(c) The proportion of cases oflung cancer giving rise to brain metastases.
Table III reviews the findings of various authors who have considered this
problem. The absence ofbrain metastases from primary bronchial tumours in the-
investigation of Krasting (1906) is noteworthy, indeed the author himselfremarks.
TABLE III.-Reported Frequency of Brain Metastasesfrom
Primary Carcinoma of the Lung
Author.
Krasting (1906)
Grant (1926) .
Elkington (1936)
Courville (1950)
Brunner (1936)
Rupp (1948) .
Berglund & Raaf (1950)
Lenshoeck (1950)
Heppner (1952)
Dates of
examinations.
1871-1905
1913-1926
1918-1933
1918-1948
1920-1933
1928-1948
1937-1949
1939-1948
1947-1951
Number of
histologically
verified cases
of brain
metastases.
53
26
72
221
74
42
36
20
121
Percentage of
those with brain
metastases who had
primarycarcinoma.
of the bronchus.
0-0
23.0
33-3
39 36
37-8
50-0
25-0
45.0
39.5
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,on this finding. In a series of 1078 necropsies revealing carcinomas there were
orly 19 primary lung tumours compared with 309 stomach tumours, 159 uterine
-tumours and 101 oesophageal tumours. This figure is too low to be helpful in
the assessment of the incidence of brain metastases. Similar studies made in the
latter part of the nineteenth century would, however, be most interesting and
should be looked for more carefully than we have been able to do. Apart from
this group, despite a variation from 23 to 50 per cent between individual reports,
no evidence has been found of a tendency for any change in the incidence of
brain metastases due to bronchial carcinoma over the last 30 years.
Multiplicity and association of brain metastases.
In this investigation we have chosen the word " single " to describe a brain
metastasis which forms one isolated continuous mass. Others we have called
" multiple ". Furthermore, if no secondaries were found elsewhere in the body,
we have called the deposits in the brain " solitary ". If, however, other
metastases were found elsewhere, then we have used the word " associated ".
These two notions of multiplicity and association thus give rise to four categories
and it is interesting to see how the 166 instances ofbrain metastases in the inquiry
fit into these four groups.
The figures which are set out in Table IV seem to indicate some dependence
between the multiplicity and association of brain secondaries. It would appear
that if metastases are present elsewhere in the body in addition to the brain,
then the deposits in the brain are more likely to be multiple. Little or no
difference in the multiplicity and association of brain secondaries is to be found
between the three histological types.
TABLE IV.-Distribution of Brain Metastases according to
Multiplicity and Association
Single. Multiple. Total.
Solitary . 23 . 18 . 41
(13*9%) (10.8%) (24- 7%)
Associated . . 37 88 . 125
(22*3%) (53*0%) (75*3%)
Total. . 60 . 106 . 166
(36.2%) (6388%) (100%/)
The question of association can be pursued further by considering the actual
sites of the other associated metastases. We have seen that in the series as a
whole the incidence of brain metastases is 25-7 per cent. It follows that if we
take any sub-group of the series, say those with adrenal metastases, and consider
the incidence of cerebral metastases in this sub-group, then this figure should also
not depart significantly from 25 7 per centifadrenal andcerebral metastases occur
quite independently. Table V shows the results of carrying out this procedure
for six organs.
All the percentages except one are greater than the comparative figure of 25-7
per cent and, of course, this merely reflects the fact that metastases at any sites
tend to be associated one with another. However, this does not explain why the
percentages differ so much among themselves. These differences might have
some important significance or merely reflect relative lethality. Liver metastases
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TABLE V.-Association of Brain Metastases with Metastases in Other Organs
Number of necropsies Percentage with
with metastases in Number with brain brain metastases
Other organ. other organ. metastases also. also.
Liver . . 249 . 56 22- 5
Adrenals . . 225 . 85 . 37- 8
Kidneys . . 101 . 40 . 39.6
Pancreas . . 77 39 . 51
Thyroid . . 24 . 8 . 33
Spleen . . 34 . 9 . 26
and brain metastases both tend to cause death relatively quickly so that the
occurrence of one may preclude the onset of the other. Hence we have a low
percentage (22.5) of liver metastases associated with brain metastases. In a
similar way the high percentage (51) for pancreas may be a consequence of a
relatively low lethality of metastases in this organ.
The site of metastases in the brain
For this purpose we have had regadr merely to the division of the brain into
the cerebrum and cerebellum and have considered only the distribution of single
metastases in these two parts.
A distribution of metastases in the brain which bears no relation to the sizes of
the cerebrum and cerebellum might be used to infer something as to the route
ofspread into the brain. However, ofsixtysinglebrainmetastases, 23 (38percent)
were located in the cerebellum, a proportion which seems at least consistent with
a fairly uniform distribution.
SUMMARY
In a series of 647 full necropsies on patients with bronchial carcinoma the
brain was found to be involved in 166 cases (26 per cent): it is thought that the
usual proportion may be nearer 30 per cent.
Brain metastases from undifferentiated tumours and adenocarcinomas were
found to be about equally frequent (30-33 per cent) but to occur relatively
infrequently from squamous-ce]led carcinomas (10-7 per cent). The computation
of similar proportions based on all necropsies revealing any metastases serves to
emphasize the rate for adenocarcinomas.
Sincethe beginning ofthe centurythere has been atendencyfortheproportions
of necropsies reported which reveal brain secondaries to increase from 10-15 per
cent to 25-30 per cent though there are exceptions at both ends ofthe time scale.
A study ofthe proportion of brain secondaries reported which were found to have
arisen from bronchial primaries showed no upwrad trend since the turn of the
century.
A brain secondary appears rather more likely to be single if it is also solitary,
that is, unaccompanied by secondaries elsewhere in the body.
Brain and liver secondaries tend not to be present together at death while
brain and pancreas secondaries are much more likely to be concurrent. These
phenomena may, however, only represent a manifestation of relative lethality.
Considering only single metastases there is found to be no significant deviation
from the expected proportions ofsecondaries lodged in the cerebrum (62 per cent)
and cerebellum (38 per cent).
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This study does not add weight to the suggestion that the major proportion
of the increase in death certification for bronchial carcinoma has in fact been due
to a real increase in the disease.
We should like to reiterate our thanks to all pathologists referred to in our
previous article on this subject, namely; Professor T. Crawford, Professor J. H.
Dible, Professor R. W. Scarff, Dr. A. B. Bratton, Dr. C. C. Bryson, Dr. A. G.
,Signy, Dr. M. Gillespie and Dr. J. W. Whittick. We must reaffirm that, while so
generously providing us with access to their records, these pathologists must in no
way be held responsible for any conclusions which have been drawn.
Once again we wish to thank Professor Smithers for his many helpful
.suggestions and assistance in preparing the text.
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